Skip to Content
Penn LDI
  • Fellows
    • Fellow Directory
    • Fellow Resources
    • Become an LDI Fellow
  • Our Work
    • Focus Areas and Initiatives
    • Research & Policy Updates
    • In the Media
    • Working Groups
  • Events
  • Education
    • Research Training Programs
    • Translation and Dissemination Training Programs
    • Affiliated Degree Programs
  • About Us
    • Welcome
    • Partners
    • Governance and Committees
    • Staff
    • History
    • Contact Us
    • 2025: The Year in Impact
  • Giving

Search Results

In The Media STAT News

FDA Unveils Rules for Bespoke Gene Therapies, Predicting Flood of Rare Disease Applications 

Interview

Featured Fellow:
  • Holly Fernandez Lynch, JD, MBE
February 23, 2026

Blog Post

Venture Philanthropy Transformed Cystic Fibrosis. Can It Deliver for Other Diseases?

CF Foundation’s Landmark Drug Approvals With Vertex Inspired Patient Groups to Act Like Biotech Investors. But Only a Few Groups Have Made Big Bets, LDI Fellow Finds

By:
  • Karl Stark
January 28, 2026

In The Media STAT News

FDA’s New ‘Plausible Mechanism Pathway’ for Personalized Gene Editing Raises Concerns

Extended Interview

Featured Fellow:
  • Holly Fernandez Lynch, JD, MBE
January 26, 2026

In The Media STAT News

FDA Delays Reviews for Two Drugs in New Voucher Program

Interview

Featured Fellow:
  • Holly Fernandez Lynch, JD, MBE
January 16, 2026
Modern megaphone on purple background

Blog Post

Impact: LDI Fellows Shaped Public Discussion and Public Policy in 2025

Highlighting 10 Ways LDI Fellows Put Their Research Into Action

By:
  • LDI Staff
January 6, 2026

In The Media STAT News

FDA Review Staff was Excluded from Voting on Whether to Approve First Priority Voucher Drug

Interview

Featured Fellow:
  • Holly Fernandez Lynch, JD, MBE
November 21, 2025
Four pills sitting on top of a magnifying glass with a clock in the background.

In Their Own Words

These Patients Have Nothing Else. Should That Be Enough for FDA Drug Approval?

Despite Streamlined Processes, FDA’s Role in Rare-Disease Drug Development Draws Continued Scrutiny

By:
  • Holly Fernandez Lynch, JD, MBE
  • and Remsha Ramachandran, MD, MPP, MHS
October 21, 2025

In The Media The New York Times

How Private Equity Oversees the Ethics of Drug Research

Interview

Featured Fellow:
  • Holly Fernandez Lynch, JD, MBE
October 4, 2025

In The Media KFF Health News

Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs

Interview

Featured Fellow:
  • Holly Fernandez Lynch, JD, MBE
September 12, 2025

In The Media Bloomberg

Right to Try Movement Finds Powerful Allies Under Trump

Interview

Featured Fellow:
  • Holly Fernandez Lynch, JD, MBE
August 19, 2025

In The Media Bloomberg

How the Moms and Dads of Patients Won Sarepta’s Drug a Reprieve

Interview

Featured Fellow:
  • Holly Fernandez Lynch, JD, MBE
August 18, 2025

Policy

Policy Recommendations for Strengthening the Accelerated Approval Program for Oncology Drugs

Memo: Delivered to the U.S. Food and Drug Administration (FDA)

By:
  • Holly Fernandez Lynch, JD, MBE
  • Steven Joffe, MD, MPH
July 15, 2025

Join Our Newsletter List!

Get the latest Penn LDI news, research, events, and opportunities.

Sign Up
Penn LDI
Colonial Penn Center, 3641 Locust Walk
Philadelphia, PA 19104-6218
  • Email LDI
  • Accessibility
  • Disclaimer
  • Privacy
  • Copyright
P:215-898-5611F:215-898-0229

© 2026 University of Pennsylvania

  • linkedin
  • youtube

Menu

  • Fellows
    • Fellow Directory
    • Fellow Resources
    • Become an LDI Fellow
  • Our Work
    • Focus Areas and Initiatives
    • Research & Policy Updates
    • In the Media
    • Working Groups
  • Events
  • Education
    • Research Training Programs
    • Translation and Dissemination Training Programs
    • Affiliated Degree Programs
  • About Us
    • Welcome
    • Partners
    • Governance and Committees
    • Staff
    • History
    • Contact Us
    • 2025: The Year in Impact
  • Giving

Search